Daily Ards Research Analysis
Three studies advance ARDS science across mechanism, modeling, and prognosis. A mechanistic study identifies the LPAR1–NF-κB axis as a driver of alveolar hypercoagulation and impaired fibrinolysis. A randomized porcine model disentangles surgical versus ventilator and hyperoxia injury during one-lung ventilation, and a human cohort links serum miR-27a/FOXO3 to ARDS severity and 28-day mortality.
Summary
Three studies advance ARDS science across mechanism, modeling, and prognosis. A mechanistic study identifies the LPAR1–NF-κB axis as a driver of alveolar hypercoagulation and impaired fibrinolysis. A randomized porcine model disentangles surgical versus ventilator and hyperoxia injury during one-lung ventilation, and a human cohort links serum miR-27a/FOXO3 to ARDS severity and 28-day mortality.
Research Themes
- Coagulation–inflammation crosstalk in ARDS
- Translational modeling of perioperative lung injury
- Prognostic biomarkers for pneumonia-related ARDS
Selected Articles
1. LPAR1 Promotes Activation of Pathways Alveolar Hypercoagulation and Fibrinolytic Inhibition in ARDS via NF-κB Signaling Pathway.
Using LPS-induced rat ARDS and LPAR1 overexpression/knockdown, the study shows that LPAR1 aggravates lung injury, increases TF, PAI-1, and thrombin activity in BALF, and enhances NF-κB activation; genetic downregulation attenuates these effects. In AECII, LPAR1 rises 6–24 h post-LPS, promoting TF and PAI-1 via NF-κB, which is reversed by NF-κB inhibition.
Impact: Identifies a targetable LPAR1–NF-κB axis driving dysregulated alveolar coagulation/fibrinolysis, a core ARDS pathology. Provides convergent in vivo and in vitro evidence enabling translational drug discovery.
Clinical Implications: LPAR1 antagonism and NF-κB modulation merit evaluation as strategies to mitigate alveolar hypercoagulability and impaired fibrinolysis in ARDS, potentially reducing refractory hypoxemia and ventilator-induced injury.
Key Findings
- LPAR1 overexpression exacerbated LPS-induced lung injury and increased lung W/D ratio in rats; knockdown reduced these effects.
- LPAR1 upregulated TF, PAI-1 expression and activity, and thrombin activity in BALF; knockdown blunted these changes.
- LPAR1 amplified LPS-induced NF-κB activation; NF-κB inhibition reversed LPAR1-driven TF/PAI-1 upregulation in AECII.
- LPAR1 expression in AECII rose at 6 h, peaked at 24 h post-LPS, then declined.
Methodological Strengths
- Integrated in vivo ARDS model with genetic overexpression/knockdown and in vitro AECII validation
- Mechanistic rescue using NF-κB inhibition strengthens causal inference
Limitations
- LPS-induced ARDS model may not fully recapitulate human heterogeneity
- Lack of human tissue or clinical validation; limited assessment of endothelial/immune compartments
Future Directions: Test selective LPAR1 antagonists and NF-κB modulators in multi-hit ARDS models and validate LPAR1/TF/PAI-1 signatures in human BALF/plasma to inform early-phase trials.
Alveolar hypercoagulation and fibrinolytic inhibition are critical mechanisms contributing to refractory hypoxemia in acute respiratory distress syndrome (ARDS). The nuclear factor kappa-B (NF-κB) pathway is known to play a role in these processes. Lysophosphatidic acid receptor 1 (LPAR1) has been identified as being associated with the NF-κB pathway. We hypothesize that LPAR1 may regulate alveolar hypercoagulation and fibrinolytic inhibition in ARDS, potentially through modulation of the NF-κB pathway. The rat model of acute respiratory distress syndrome (ARDS) was induced via inhalation of lipopolysaccharide (LPS). In some rats, pulmonary tissue was subjected to either overexpression or knockdown of the LPAR1 gene using lentiviral-mediated transfection prior to LPS exposure. The impact of LPAR1 modulation on alveolar hypercoagulation, fibrinolytic inhibition, acute lung injury, and the NF-κB signaling pathway in the ARDS rat model was investigated. In vitro, the expression level of LPAR1 in LPS-stimulated type II alveolar epithelial cells (AECII) was monitored over time.
2. Establishing an in vivo large animal model of one-lung ventilation and operative lung trauma.
A randomized porcine OLV model with three arms (LPV, injurious ventilation, and protective ventilation with hyperoxia) was established during left upper lobectomy. The protocol reproducibly controlled ventilator parameters and oxygen delivery; BALF IL-6 increased with injurious ventilation, hyperoxia, and surgical exposure, supporting model sensitivity to clinically relevant insults.
Impact: Provides a reproducible, randomized large-animal platform to dissect surgical versus ventilator/hyperoxia injury during OLV—critical for preventing postoperative ALI/ARDS and testing protective strategies.
Clinical Implications: Supports optimizing intraoperative ventilation and oxygen targets during OLV and enables preclinical testing of VILI mitigation strategies to reduce postoperative ALI/ARDS risk.
Key Findings
- Developed a randomized porcine OLV model with three arms: LPV (n=5), injurious ventilation (n=5), and protective ventilation with hyperoxia (n=6).
- Successfully and reproducibly maintained target peak airway pressures, tidal volumes, and oxygen delivery across groups.
- BALF IL-6 was elevated with injurious ventilation during OLV, hyperoxia, and surgical exposure, indicating inflammatory injury.
- Collected physiologic data and biospecimens enabling downstream analyses of VILI versus surgical trauma.
Methodological Strengths
- Randomized allocation across multiple clinically relevant exposure arms
- Large-animal (porcine) surgical model with standardized lobectomy and comprehensive physiologic/biologic sampling
Limitations
- Pilot sample size limits power and external generalizability
- Outcomes centered on short-term inflammatory markers rather than long-term clinical endpoints
Future Directions: Use the platform to test protective ventilation, oxygen titration, pharmacologic anti-inflammatory/antioxidant strategies, and to quantify histologic injury and long-term outcomes.
BACKGROUND: Respiratory complications, including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), are important causes of morbidity and mortality among lung surgery patients. Lung surgery introduces surgical and atelectatic trauma to the operated lung, while one-lung ventilation (OLV) applied to the contralateral lung is also a suspected mechanism of ventilator-induced lung injury (VILI). Our goal was to develop a large animal model to assess the relative lung injury induced by surgical and ventilator trauma during left upper lobectomy in juvenile pigs. METHODS: Sixteen pigs (24-32 kg) were randomly assigned to one of three OLV exposure groups. The control group (n = 5) was exposed to lung-protective ventilation (LPV) during OLV, the second group (n = 5) was exposed to potentially injurious ventilation (IMV) during OLV using higher tidal volume and peak airway pressure and the third group (n = 6) was exposed to hyperoxia with protective ventilation (LPV-HO) for the duration of OLV and surgery.
3. Serum miR-27a Reduction and FOXO3 Elevation in Elderly Patients with Severe Pneumonia Complicated with ARDS: Association with Disease Severity and Prognosis.
Compared with controls and non-ARDS pneumonia, ARDS patients had lower serum miR-27a and higher FOXO3, with stepwise changes across ARDS severity. miR-27a correlated positively and FOXO3 negatively with oxygenation; combined detection improved 28-day mortality prediction (AUC 0.867). Age, prolonged ventilation, and high FOXO3 were risk factors, while higher oxygenation and miR-27a were protective.
Impact: Proposes a biologically plausible, readily measurable biomarker pair for risk stratification in pneumonia-related ARDS, linking molecular signaling to bedside prognosis.
Clinical Implications: Combined serum miR-27a/FOXO3 could augment existing scores for early triage and monitoring in elderly pneumonia with ARDS; prospective multicenter validation is needed before integration into practice.
Key Findings
- Serum miR-27a decreased and FOXO3 increased across controls, non-ARDS pneumonia, and ARDS (P<0.001), with stepwise changes by ARDS severity.
- miR-27a correlated positively with oxygenation index (r=0.635), FOXO3 negatively (r=-0.672), and miR-27a inversely with FOXO3 (r=-0.624).
- Combined miR-27a and FOXO3 improved 28-day mortality prediction (AUC 0.867) compared to single markers; 28-day mortality was 30.7% in ARDS.
- Logistic regression: age, prolonged ventilation, and high FOXO3 were risk factors, while higher oxygenation index and miR-27a were protective.
Methodological Strengths
- Defined comparison groups (controls, severe pneumonia without ARDS, with ARDS) and ARDS severity stratification
- Multiple statistical approaches (correlation, multivariable logistic regression, ROC analysis) with qRT-PCR quantification
Limitations
- Retrospective single-center design without external validation
- Biomarker thresholds and temporal dynamics not standardized; no interventional testing
Future Directions: Prospective, multicenter validation with predefined thresholds and integration with clinical scores; assess longitudinal kinetics and responsiveness to therapy.
OBJECTIVE: To clarify the expression of microRNA-27a (miR-27a) and forkhead box protein O3 (FOXO3) in elderly patients with severe pneumonia complicated with acute respiratory distress syndrome (ARDS), and evaluate their relationship with disease severity and prognosis. METHODS: A total of 189 elderly patients with severe pneumonia were retrospectively analyzed, including 114 with ARDS (Group A) and 75 without ARDS (Group B). Seventy healthy individuals served as controls. Group A was further divided into mild (n=28), moderate (n=36), and severe (n=50) subgroups based on oxygenation index, and into survival (n=79) and death (n=35) subgroups based on 28-day outcome. Serum miR-27a and FOXO3 mRNA were measured by qRT-PCR. Their correlations with oxygenation index and prognosis were analyzed using Pearson, Spearman, logistic regression, and ROC curve methods.